IDXX

2024Q3BMO

IDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2024-10-31 · Fiscal end 2024-09-30 · Features as of 2024-10-30

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.69
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.4%
IV front—
P/C full—
P/C front—
Features as of2024-10-30

Run-up

Close—
Ret 5d-1.5%
Ret 10d-2.8%
Ret 20d-7.2%
Ret 30d-11.8%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.80Beat
Estimated EPS2.69
Actual revenue
975.5M
Surprise %+4.1%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction-5.4%
Implied vs actual

Implied 2.4%Actual 4.7%

Gap reaction-4.7%
Day result-9.8%
Next-day upNo
Realized / IV1.93×

Post tape

Post 5d+6.4%
Post 10d+4.1%
Post volume2.0M
Vol ×10d2.90×
Vol ×20d3.38×
Post range5.9%